{
    "2018-07-01": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Insider Buys Of The Week: AbbVie, Energen, NuStar And More",
                "features": {
                    "keywords": [
                        "Insider Buys",
                        "AbbVie",
                        "Energen",
                        "NuStar"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "energy",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Pharma's 2 Biggest Setbacks in 2018",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Setbacks",
                        "2018"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Pharma's 2 Biggest Setbacks in 2018",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Setbacks",
                        "2018"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "AbbVie Says Will Appeal $448 Mln Antitrust Judgment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Appeal",
                        "Antitrust",
                        "Judgment"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}